文献速递药疹与重症皮肤不良反应自身免疫性与大疱性皮肤病

SCORTEN预测SJS/TEN预后的准确性:系统评价与Meta分析

Accuracy of SCORTEN to predict the prognosis of Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2020-01-07

合并log(SMR)为-0.0889(95%CI:-0.2023至0.0245),提示SCORTEN作为死亡预测工具表现合理。多因素Meta回归显示患者平均年龄和研究的结束年份是显著影响SCORTEN预测的因素。

要点

  • SCORTEN对SJS/TEN死亡预测总体准确,合并log(SMR)为-0.0889(95%CI:-0.2023至0.0245)。
  • 患者平均年龄升高与观察/预期比值显著增加相关。
  • SCORTEN≤3时低估死亡率,>3时高估死亡率(评分范围0-7)。

核心结论

  • SCORTEN对SJS/TEN死亡预测总体准确性显著,但共病、受累体表面积和患者年龄等因素的影响提示可能需要重新定义该量表。

研究设计与样本

  • 系统检索MEDLINE、Cochrane Library、EMBASE、SCOPUS和Web of Knowledge,无语言限制,最后更新至2019年2月5日。
  • 以标准化死亡比(SMR)即观察死亡数与SCORTEN预期死亡数之比作为分析指标。

主要发现

  • 合并log(SMR)为-0.0889(95%CI:-0.2023至0.0245),提示SCORTEN作为死亡预测工具表现合理。
  • 多因素Meta回归发现患者平均年龄和研究结束年份是仅有的显著影响SCORTEN预测的因素。
  • 患者平均年龄与观察/预期比值显著增加相关,观察/预期比值随年份推移逐渐降低。
  • SCORTEN≤3时存在死亡率低估,SCORTEN>3时存在死亡率高估(评分范围0-7)。

关键数值与推荐

  • 合并log(SMR):-0.0889(95%CI:-0.2023至0.0245)。
  • SCORTEN评分范围0-7,≤3低估死亡率、>3高估死亡率。

临床怎么用

  • SCORTEN可用于SJS/TEN患者死亡风险预测,但解读时应考虑患者年龄、研究年代及共病(如肾功能损害)等因素。
  • 对SCORTEN≤3的患者需警惕实际死亡率可能被低估,对>3者需注意可能高估。

局限性

  • 疾病罕见。
  • 纳入研究异质性大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The SCORTEN score is a specific predictor of the probability of death for patients diagnosed with Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). OBJECTIVES: To evaluate the overall accuracy of SCORTEN and the influence of several moderators such as age, sex, geographical region and age of the study. METHODS: A systematic search was performed on MEDLINE, The Cochrane Library, EMBASE, SCOPUS and Web of Knowledge, with no restriction on language (last update 5 February 2019 for all databases). Original studies on the use of SCORTEN were eligible. The standardized mortality ratio (SMR), defined as the quotient between the number of deaths observed and the number expected following SCORTEN, was taken as the measurement of analysis. RESULTS: Sixty-four papers were part of the main meta-analysis carried out in the study. A pooled log(SMR) of -0.0889 (95% CI: -0.2023 to 0.0245) was obtained, suggesting a reasonable behaviour of SCORTEN as a predictor of mortality. The possible influence of several factors in the accuracy of SCORTEN was studied by means of meta-regression models. Multivariate meta-regression allowed finding that the mean age of the patients and the ending year of the study are the only factors that significantly influence SCORTEN predictions. The mean age of the group of patients was associated with a significant increase in the observed/expected ratio, whereas a progressive reduction in the observed/expected ratio can be appreciated over the years. Finally, an underestimation of mortality was found for SCORTEN values of 3 or less and the opposite for those above 3 (SCORTEN range: 0-7). CONCLUSIONS: The rarity of the disease and the heterogeneity of the studies included are major limitations. Despite the overall remarkable accuracy displayed by SCORTEN, the influence of several factors, as comorbidities (e.g. renal impairment), involved body surface area and patient's age, seem of enough relevance to consider a redefinition of the scale.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Torres-Navarro I, Briz-Redón Á, Botella-Estrada R, et al. Accuracy of SCORTEN to predict the prognosis of Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2020. PMID: 31912590. doi:10.1111/jdv.16137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。